Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Mar
9
2013
Preliminary Answers from Environmental Protection Agency (EPA) on the Viability of the PM 2.5 (Air Quality Analysis) Significant Impact Level Michael Best & Friedrich LLP
Apr
12
2013
Proposed Revisions to Department of Natural Resources Wisconsin Environmental Policy Act (WEPA) Rules Are Out for Public Hearing and Comment Michael Best & Friedrich LLP
Jul
25
2013
Patent Term Extension in Russia Michael Best & Friedrich LLP
May
23
2014
2013-2014 Wisconsin Legislative Session Ends & Three Additional Agriculture Bills Signed Into Law Michael Best & Friedrich LLP
Feb
16
2015
Revised Seed Law Expected to Come into Effect Soon in China Michael Best & Friedrich LLP
Sep
25
2015
Amgen At It Again – Sues Hospira For Not Wanting To Dance Over Biosimilar Michael Best & Friedrich LLP
Nov
20
2015
New Gluten-Free Labeling Requirements for Fermented Foods Michael Best & Friedrich LLP
Mar
9
2016
Roche v. Biocad – Patent Litigation Likely to Shape Russia’s IP Landscape Michael Best & Friedrich LLP
Oct
3
2016
Ukraine’s Competition Authority Issues Major Decision on Drug Pricing Practices Michael Best & Friedrich LLP
Jan
6
2017
Delhi High Court Strikes Down Section 24(5) of the Plant Varieties Act as Unconstitutional Michael Best & Friedrich LLP
Aug
8
2017
PTAB Obviousness Determination Vacated and Remanded for Flawed Analysis of Unexpected Results Michael Best & Friedrich LLP
Dec
28
2010
President Signs Tax Bill with Numerous Renewable Energy Implications Michael Best & Friedrich LLP
Jun
13
2012
Chinese Investors Looking to Invest $100M in Wisconsin Companies — June 15, 2012 Deadline for Early Consideration Michael Best & Friedrich LLP
Jun
27
2013
Recent Brazilian Federal Court Decision Involving Genetic Heritage and Traditional Knowledge Michael Best & Friedrich LLP
Aug
8
2013
EPA Targets Concentrated Animal Feeding Operations (CAFO) for Criminal Enforcement Actions under the Clean Water Act; CAFOs to Continue to be National Enforcement Priority for EPA in FY 2014-2016 Michael Best & Friedrich LLP
Aug
30
2013
EPA’s Final Rule on Solvent-Contaminated Wipes Reduces Regulatory Burden Michael Best & Friedrich LLP
Oct
14
2014
First Mailbox Appeal to be decided by the Federal Court of Appeals in Brazil Michael Best & Friedrich LLP
Dec
8
2014
The Breadth of India’s “Bolar Exemption” Michael Best & Friedrich LLP
Jan
12
2015
Inching Closer to the First Biosimilar Approval in the U.S. Michael Best & Friedrich LLP
Mar
9
2015
U.S. FDA Approves the First Biosimilar Product Michael Best & Friedrich LLP
Jul
27
2015
FDA Proposes Further Revisions to Nutritional Facts Label Michael Best & Friedrich LLP
Nov
30
2015
Biologics and Biosimilar Bits and Bytes – November 30, 2015 Michael Best & Friedrich LLP
Mar
9
2017
Green Groups Petition EPA to Overhaul CAFO Regulations Michael Best & Friedrich LLP
Feb
25
2011
EPA Issues Final Boiler MACT Rules Michael Best & Friedrich LLP
Mar
10
2013
Wisconsin Department of Natural Resources (WDNR) Draft Guidance on Pollutant (TMDL/WPDES) Permit; Implementation Is Open for Public Comment Michael Best & Friedrich LLP
Aug
8
2013
Wisconsin Governor Walker Signs Wisconsin State Budget Bill Into Law Michael Best & Friedrich LLP
Nov
3
2013
Request for Public Comments by ANVISA (National Sanitary Vigilance Agency) on the Interchangeability of Branded Generic Drugs with Reference Drugs in Brazil Michael Best & Friedrich LLP
Jun
4
2014
Availability of Biosimilar Pathways and Data/Marketing Exclusivity Globally Michael Best & Friedrich LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins